First Opinion Yap Boum II and Sunil Parikh How a checklist can help decolonize global health research
First Opinion Stacey McKenna STAT Plus: Making naloxone available over the counter won’t solve the overdose crisis — but it will help
First Opinion Steven Server and Samuel Schotland It’s time to retire ‘poor historian’ from clinicians’ vocabularies
Politics Sarah Owermohle STAT Plus: Health groups like AHA, PhRMA channeled millions into end-of-year legislative debates
Politics Rachel Cohrs STAT Plus: PhRMA terminates lobbying contract with White House official’s brother
First Opinion Sergio Imparato and Sarosh Nagar The WHO’s new pandemic treaty is good for the world — and the U.S.
First Opinion Danielle Ofri STAT Plus: Even with lawsuits and copay caps, will insulin ever be affordable?
First Opinion Juergen Eckhardt and George Church Disruptive science is leaping forward, not limping along
First Opinion Juliana M. Reed STAT Plus: A watershed year for biosimilars — if regulators and policymakers step up
First Opinion Emil D. Kakkis STAT Plus: As it turns 40, the Orphan Drug Act for rare diseases needs a refresh
First Opinion Vanessa Kerry Leaders at Davos need to pay attention to the crossroads of climate change, health, and security
First Opinion Nick Hayes For addiction treatment, longer is better. But insurance companies usually cut it short
First Opinion Jerome H. Kim There are 4 gaps in global pandemic responses. The biggest is missing leadership
Politics Sarah Owermohle STAT Plus: Rep. Jason Smith and the other Republicans leading health policy in the House
First Opinion Jennifer W. Tsai and Hazar Khidir Emergency Medical Treatment and Labor Act is no end-run around abortion bans
First Opinion Bonnielin Swenor, Lisa I. Iezzoni and Steven Barnett NIH advances landmark recommendations on disability inclusion and anti-ableism
First Opinion Jason Kletter Allowing pharmacies to dispense methadone is dangerous for patients and communities
First Opinion Amar Kelkar, Julie Kanter and Payal Desai Specialized centers can help realign the U.S.’s moral compass for sickle cell disease
First Opinion Rhea Boyd, Bruce Lesley and Alexandra Quinn Reducing the threat of vaccine-preventable diseases starts with kids
First Opinion Trisha S. Pasricha The art of the ‘deceased note’: A physician grapples with documenting patients’ final moments
Politics Rachel Cohrs and Sarah Owermohle STAT Plus: AbbVie exits major pharmaceutical industry lobbying groups
First Opinion Matthew Gibbs STAT Plus: Fixing price instability can improve access to affordable prescription drugs
A STAT Investigation Nicholas Florko Getting hepatitis C treatment opens new doors for the incarcerated
A STAT Investigation Nicholas Florko Watch: With little more than a typewriter, an Idaho man overturns the entire state’s policy on hepatitis C treatment in prison
A STAT Investigation Nicholas Florko Hundreds of incarcerated people are dying of hep C — even though we have a simple cure